IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
26 hedge funds and large institutions have $11.2M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$277K | |
| 2 | +$269K | |
| 3 | +$216K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$102K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$53K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$615K | |
| 3 | -$598K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$420K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$70.3K |